PriceTargets.com logo

Protech Home Medical - PTQ Stock Price Target and Predictions

  • Consensus Rating: N/A
  • Consensus Price Target: C$0.00
  • Forecasted Upside: -100.00%
  • Number of Analysts: 0
  • Breakdown:
  • 0 Sell Ratings
  • 0 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
C$8.24 As of 05/13/2021 12:59 AM ET
▼ -0.44 (-5.07%)

This chart shows the closing price for PTQ by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Protech Home Medical Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for PTQ and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for PTQ

Analyst Price Target is C$0.00
▼ -100.00% Downside Potential
This price target is based on 0 analysts offering 12 month price targets for Protech Home Medical in the last 3 months. The average price target is C$0.00, with a high forecast of C$0.00 and a low forecast of C$10,000,000.00. The average price target represents a -100.00% upside from the last price of C$8.24.

This chart shows the closing price for PTQ for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart




Current Consensus is N/A

The current consensus among 0 contributing investment analysts is to n/a stock in Protech Home Medical. This N/A consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/27/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/25/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/25/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
7/24/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
10/22/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
1/20/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
3/20/2024
  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings
Ratings as of
4/19/2024

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 0 hold ratings
  • 0 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetDetails
3/3/2021Raymond JamesSet TargetOutperformC$3.00
2/2/2021Raymond JamesSet TargetOutperformC$3.00
2/1/2021Beacon SecuritiesReiterated RatingBuy
1/25/2021Raymond JamesBoost TargetOutperformC$2.00 ➝ C$3.00
12/15/2020Raymond JamesSet TargetOutperformC$2.00
7/9/2020M PartnersReiterated RatingBuy
5/21/2020Dougherty & CoSet TargetBuyC$2.25
1/21/2020Echelon Wealth PartnersReiterated RatingBuy
(Data available from 4/19/2019 forward)

News Sentiment Rating

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
9/22/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
10/22/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
11/21/2023
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
12/21/2023
  • 0 very positive mentions
  • 1 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
1/20/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
2/19/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/20/2024
  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
4/19/2024

Current Sentiment

  • 0 very positive mentions
  • 0 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

  • No positive mentions tracked during this time.

Very Positive

  • No very positive mentions tracked during this time.
Protech Home Medical logo
Protech Home Medical Corp. provides in-home monitoring equipment, supplies, and services for patients in the United States. It offers daily and ambulatory aides; power mobility equipment; BiPAP and CPAP machines, oxygen concentrators, and ventilators; oxygen therapy; sleep apnea and PAP treatment equipment; disease management services; and home ventilator equipment, as well as rents respiratory equipment. The company was formerly known as Patient Home Monitoring Corp. and changed its name to Protech Home Medical Corp. in April 2018. Protech Home Medical Corp. was incorporated in 1993 and is headquartered in Wilder, Kentucky.
Read More

Today's Range

Now: C$8.24
Low: C$8.04
High: C$8.60

50 Day Range

MA: C$8.24
Low: C$8.24
High: C$8.24

52 Week Range

Now: C$8.24
Low: C$0.98
High: C$8.60

Volume

184,783 shs

Average Volume

445,429 shs

Market Capitalization

C$232.51 million

P/E Ratio

N/A

Dividend Yield

N/A

Beta

N/A

Frequently Asked Questions

What sell-side analysts currently cover shares of Protech Home Medical?

The following equities research analysts have issued research reports on Protech Home Medical in the last year:
View the latest analyst ratings for PTQ.

What is the current price target for Protech Home Medical?

0 Wall Street analysts have set twelve-month price targets for Protech Home Medical in the last year. has the lowest price target set, forecasting a price of C$10,000,000.00 for Protech Home Medical in the next year.
View the latest price targets for PTQ.

What is the current consensus analyst rating for Protech Home Medical?

Protech Home Medical currently has from Wall Street analysts. The stock has a consensus analyst rating of "N/A."
View the latest ratings for PTQ.

What other companies compete with Protech Home Medical?

Other companies that are similar to Protech Home Medical include Quipt Home Medical, Hamilton Thorne, Profound Medical, Viemed Healthcare and ESSA Pharma. Learn More about companies similar to Protech Home Medical.

How do I contact Protech Home Medical's investor relations team?

The company's listed phone number is 859-300-6455. The official website for Protech Home Medical is www.protechhomemedical.com. Learn More about contacing Protech Home Medical investor relations.